Nifurtimox bulk supplier for pharma manufacturers

Nifurtimox Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 30 mg, 120 mg

Reference Brands: Lampit (USA)

Category: Anti Viral

Nifurtimox is an antiprotozoal medicine used to treat parasitic infections, including Chagas disease and African trypanosomiasis (sleeping sickness). It works by generating toxic radicals inside the parasite, damaging its DNA and killing it. Nifurtimox is available in Tablet and strengths such as 30 mg, 120 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Nifurtimox is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Nifurtimox can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Nifurtimox is used to treat Chagas disease, an infection caused by the parasite

Nifurtimox is a nitrofuran derivative. Its chemical structure enables it to generate reactive intermediates that selectively damage parasitic cells while minimizing harm to human cells. The formulation includes standard pharmaceutical excipients suitable for oral administration.

Common trade names include Lampit and Nifurtimox Tablets (marketed regionally under different names).

Lampit is produced by Bayer HealthCare Pharmaceuticals. Generic versions are also manufactured by multiple GMP-certified companies in different regions.

The generic name is nifurtimox.

Brand names include Lampit and Nifurtimox Tablets.

Nifurtimox is manufactured in GMP-certified facilities by Bayer and other licensed manufacturers worldwide to supply both branded and generic versions for global distribution.

Yes, Nifurtimox is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Nifurtimox is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Maraviroc

Strength:
150 mg, 300 mg, 20 mg

Form: Tablets / Oral solution

Reference Brands: Selzentry (USA), Celsentri (EU)

View Details
Maribavir

Strength:
200 mg

Form: Tablets

Reference Brands: Livtencity (USA/EU)

View Details
Raltegravir

Strength:
100mg, 400 mg, 600mg

Form: Tablets

Reference Brands: Isentress (USA/EU)

View Details
Enfuvirtide Acetate

Strength:
90 mg/vial

Form: Injection

Reference Brands: Fuzeon (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.